Oncolix Inc. (AEPP) wants to help women live longer.
To help accomplish that mission, the biotech firm is developing novel drugs aimed at eradicating women's cancers such as ovarian and breast cancer.
From the sidelines of the LD Micro conference in Los Angeles, Oncolix CEO Michael Redman tells TheStreet about his company's approach to developing effective treatments using revolutionary scientific research.
For more from the LD Micro Conference in La:
TheStreet at LD Micro: What CEO Dave Callaway Sees in Small Caps This Year
STK Owner The ONE Group Is Carving Its Own Unique Space in the Dining Experience
SRAX Chief Weighs in as Company Readies for Cryptocurrency Dividend
Snap Interactive's New Blockchain App Could Flip Video Chat on Its Head
Micro Caps Take the Spotlight at LD Micro Conference - Here's What to Expect
Here's How Cloud Computing Firm Fusion Is Using M&A to Get Ahead
Amazing Energy Isn't Afraid to Take on Big Oil